Abstract
Aim. Within the microbiological monitoring program, to study the prevalence of carbapenemase-producing K. pneumoniae in the healthcare organizations of the Gomel region and assess their level of resistance to antibacterial drugs. Materials and methods. For 91 clinical isolates of Klebsiella pneumoniae with multiple antibiotic resistance, isolated in Gomel and Gomel region, carbapenemase genes were detected by real-time PCR and sensitivity to antibacterial drugs was determined. Results. 68 carbapenemase producers were revealed: KPC — 1 isolate, OXA-48 — 47 isolates, NDM — 20 isolates. Carbapenemase producers were found in 11 Gomel health organizations and 8 central district hospitals of the regional centers of the Gomel region. All of them had an associated resistance to most antibiotics and retained sensitivity to colistin (91.2% sensitive isolates) and tigecycline (98.5%). Conclusion. The spread of carbapenemase-producing K. pneumoniae isolates in healthcare organizations makes it very difficult to conduct effective antibiotic therapy for patients and requires the introduction of appropriate infection control measures aimed at limiting their circulation in the hospital environment.
Highlights
Наиболее распространенными среди типами карбапенемаз являются КРС, OXA-48, а также металло-β-лактамазы (МБЛ) NDM и VIM.
В 36 странах-участниках выявлен 2301 изолят K.pneumoniae, продуцирующий карбапенемазы KPC, NDM, OXA-48, VIM [4].
В многоцентровом исследовании, выполненном в Беларуси в 2013—2014 гг., среди карбапенемонечувствительных изолятов K.pneumoniae выявлено 13 продуцентов МБЛ NDM и 17 продуцентов OXA-48, при этом большая часть продуцентов карбапенемаз (76,7%) была выделена от пациентов, госпитализированных в отделения реанимации и интенсивной терапии [3].
Summary
Наиболее распространенными среди типами карбапенемаз являются КРС, OXA-48, а также металло-β-лактамазы (МБЛ) NDM и VIM. В 36 странах-участниках выявлен 2301 изолят K.pneumoniae, продуцирующий карбапенемазы KPC, NDM, OXA-48, VIM [4]. В многоцентровом исследовании, выполненном в Беларуси в 2013—2014 гг., среди карбапенемонечувствительных изолятов K.pneumoniae выявлено 13 продуцентов МБЛ NDM и 17 продуцентов OXA-48, при этом большая часть продуцентов карбапенемаз (76,7%) была выделена от пациентов, госпитализированных в отделения реанимации и интенсивной терапии [3].
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Journal of microbiology, epidemiology and immunobiology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.